Efficacy and Safety of BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis in the Phase 3 CONFIRM Study

被引：0

作者：

Hutchinson, M. ^{[1
]}

Fox, R. J. ^{[2
]}

Phillips, J. T. ^{[3
]}

Miller, D. H. ^{[4
]}

Havrdova, E. ^{[5
]}

Kita, M. ^{[6
]}

Yang, M. ^{[7
]}

Zhang, R. ^{[7
]}

Novas, M. ^{[7
]}

Sweetser, M. T. ^{[7
]}

Viglietta, V. ^{[7
]}

Dawson, K. T. ^{[7
]}

机构：

[1] St Vincents Univ Hosp, Dublin 4, Ireland

[2] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA

[3] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA

[4] UCL, Inst Neurol, NMR Res Unit, London, England

[5] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic

[6] Virginia Mason Med Ctr, Seattle, WA 98101 USA

[7] Biogen Idec Inc, Cambridge, MA USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：683 / 683

页数：1

共 50 条

[1] Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM
Havrdova, Eva
Hutchinson, Michael
Kurukulasuriya, Nuwan C.
Raghupathi, Kartik
Sweetser, Marianne T.
Dawson, Katherine T.
Gold, Ralf
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (15) : 2145 - 2156
[2] Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study
Hutchinson, Michael
Fox, Robert J.
Miller, David H.
Phillips, J. Theodore
Kita, Mariko
Havrdova, Eva
O'Gorman, John
Zhang, Ray
Novas, Mark
Viglietta, Vissia
Dawson, Katherine T.
[J]. JOURNAL OF NEUROLOGY, 2013, 260 (09) : 2286 - 2296
[3] Safety and tolerability of BG-12 in patients with relapsing-remitting multiple sclerosis: results from the phase 3 CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study
Havrdova, E.
Phillips, J. T.
Fox, R. J.
Miller, D.
Kita, M.
Hutchinson, M.
Raghupathi, K.
Yuan, H.
Novas, M.
Sweetser, M. T.
Viglietta, V.
Dawson, K. T.
[J]. JOURNAL OF NEUROLOGY, 2012, 259 : S105 - S105
[4] Clinical Efficacy of BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
Fox, Robert
Miller, David
Phillips, J. Theodore
Arnold, Douglas
Selmaj, Krzysztof
Yang, Minhua
Zhang, Ray
Dawson, Katherine
Viglietta, Vissia
Sheikh, Sarah
Gold, Ralf
[J]. NEUROLOGY, 2013, 80
[5] Clinical Efficacy and Safety of Oral Bg-12 (Dimethyl Fumarate) In Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 Define and Confirm Studies
Bar-Or, A.
Gold, R.
Fox, R. J.
Havrdova, E.
Selmaj, K.
Kurukulasuriya, N. C.
Yang, M.
Raghupathi, K.
Novas, M.
Sweetser, M. T.
Viglietta, V.
Dawson, K. T.
Phillips, J. T.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1828 - 1828
[6] Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis
Ruggieri, Serena
Tortorella, Carla
Gasperini, Claudio
[J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 229 - 239
[7] Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the CONFIRM study
Michael Hutchinson
Robert J. Fox
David H. Miller
J. Theodore Phillips
Mariko Kita
Eva Havrdova
John O’Gorman
Ray Zhang
Mark Novas
Vissia Viglietta
Katherine T. Dawson
[J]. Journal of Neurology, 2013, 260 : 2286 - 2296
[8] An integrated analysis of the clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis from the phase 3 DEFINE and CONFIRM studies
Fox, R. J.
Miller, D. H.
Phillips, J. T.
Arnold, D. L.
Selmaj, K.
Yang, M.
Zhang, R.
Dawson, K. T.
Viglietta, V.
Sheikh, S. I.
Gold, R.
[J]. JOURNAL OF NEUROLOGY, 2013, 260 : S74 - S74
[9] Timecourse of Treatment Effects of BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis
Kappos, Ludwig
Giovannoni, Gavin
Gold, Ralf
Fox, Robert
Phillips, J. Theodore
Hotermans, Christophe
Zhang, Annie
Viglietta, Vissia
Miller, David
[J]. NEUROLOGY, 2013, 80
[10] Clinical Efficacy of BG-12 in Relapsing-Remitting Multiple Sclerosis (RRMS): Data from the Phase 3 CONFIRM Study
Fox, Robert
Miller, David
Phillips, J. Theodore
Kita, Mariko
Hutchinson, Michael
Havrdova, Eva
Yang, Minhua
Zhang, Ray
Viglietta, Vissia
Dawson, Katherine
[J]. NEUROLOGY, 2012, 78

← 1 2 3 4 5 →